Showing results (121-130 of 989) with videos related to
Sort By:
Pageof 99
Therapeutic Advances in Respiratory Disease|January 10, 2022
Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPDYiwen Gong, Yinghua Lv, Hongxia Liu, et al.Therapeutic Advances in Respiratory Disease|October 14, 2022
Healthcare resource consumption prior to asthma-related death: a nationwide descriptive studyLaurent Guilleminault, Michael Mounié, Agnès Sommet, et al.Therapeutic Advances in Respiratory Disease|October 28, 2022
Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutationsPing-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, et al.Therapeutic Advances in Respiratory Disease|September 9, 2022
The prognostic importance of the angiotensin II/angiotensin-(1-7) ratio in patients with SARS-CoV-2 infectionLuis M Amezcua-Guerra, Leonardo Del Valle, Héctor González-Pacheco, et al.Therapeutic Advances in Respiratory Disease|February 24, 2022
Early assessment of the efficacy of noninvasive ventilation tested by HACOR score to avoid delayed intubation in patients with moderate to severe ARDSLinfu Bai, Fei Ding, Weiming Xiong, et al.Therapeutic Advances in Respiratory Disease|October 8, 2021
Severe COVID-19 among patients with asthma and COPD: a report from the Swedish National Airway RegisterJohanna Karlsson Sundbaum, Lowie E G W Vanfleteren, Jon R Konradsen, et al.Therapeutic Advances in Respiratory Disease|April 16, 2019
Baseline history of patients using selexipag for pulmonary arterial hypertensionKristin B Highland, Michael Hull, Janis Pruett, et al.Therapeutic Advances in Respiratory Disease|March 3, 2022
Transbronchial lung cryobiopsy: prospective safety evaluation and 90-day mortality after a standardized examination protocolKlaus Hackner, Antonia Stadler, Felix Schragel, et al.Therapeutic Advances in Respiratory Disease|September 15, 2018
Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthmaRoberto W Dal Negro, Luca Bonadiman, Paola TurcoTherapeutic Advances in Respiratory Disease|June 27, 2019
The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in ChinaKewu Huang, Yanfei Guo, Jian Kang, et al.Pageof 99